This medication card provides information about Ipratropium bromide, including its generic and trade names, drug classification as an anticholinergic bronchodilator, recommended dosage of 1-2 tabs every 4 hours with a maximum of 8 per day, route of administration orally, nursing considerations of monitoring for signs of respiratory depression or elevated CSF pressure in patients with hepatic or renal impairment, and potential side effects of lightheadedness, dizziness, and sedation.